Meena Lopez
Mumbai, MH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Outcomes and Usability of Formoterol-Budesonide Delivered Through Synchrobreathe® in Patients With Chronic Obstructive Pulmonary Disease: The EMERGE Study.
Journal: Drugs - real world outcomes
Published: September 28, 2025
Efficacy and safety of glycopyrronium/formoterol delivered via a dry powder inhaler in patients with moderate to severe chronic obstructive pulmonary disease: Results from a multi-centre, open-label, randomised study.
Journal: Lung India : official organ of Indian Chest Society
Published: January 11, 2023
A review of the efficacy and safety of fluticasone propionate/formoterol fixed-dose combination.
Journal: Expert review of respiratory medicine
Published: June 21, 2022
Perceptions and Attitudes of Patients and Their Family Caregivers on Nebulization Therapy for COPD.
Journal: International journal of chronic obstructive pulmonary disease
Published: April 18, 2022
The emerging role of mycophenolate mofetil in interstitial lung diseases.
Journal: Expert review of respiratory medicine
Published: November 11, 2021
Assessment of asthma control in users of oral anti-asthma medications.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: July 31, 2021
Small Airways, Big Problem: Extrafine beclomethasone/formoterol in asthma and chronic obstructive pulmonary disease.
Journal: Lung India : official organ of Indian Chest Society
Published: July 14, 2021
The emerging role of nebulization for maintenance treatment of chronic obstructive pulmonary disease at home.
Journal: Lung India : official organ of Indian Chest Society
Published: March 09, 2021
Coexistence of allergic rhinitis and asthma in Indian patients: The CARAS survey.
Journal: Lung India : official organ of Indian Chest Society
Published: August 30, 2019
Real-world evaluation of the clinical safety and efficacy of fluticasone/formoterol FDC via the Revolizer® in patients with persistent asthma in India.
Journal: Pulmonary pharmacology & therapeutics
Published: August 13, 2019
Last Updated: 09/26/2026